½ÃÀ庸°í¼­
»óǰÄÚµå
1604684

¼¼°èÀÇ ¿ø°Ý ȯÀÚ ¸ð´ÏÅ͸µ ºÐ¾ß ÀΰøÁö´É ½ÃÀå : ºÎ¹®º° ¿¹Ãø(2025-2030³â)

Artificial Intelligence in Remote Patient Monitoring Market by Solution (Hardware, Services, Software), Application (Anesthesia Monitoring, Blood Glucose Monitoring, Brain Monitoring) - Global Forecast 2025-2030

¹ßÇàÀÏ: | ¸®¼­Ä¡»ç: 360iResearch | ÆäÀÌÁö Á¤º¸: ¿µ¹® 186 Pages | ¹è¼Û¾È³» : 1-2ÀÏ (¿µ¾÷ÀÏ ±âÁØ)

    
    
    




¡á º¸°í¼­¿¡ µû¶ó ÃֽŠÁ¤º¸·Î ¾÷µ¥ÀÌÆ®ÇÏ¿© º¸³»µå¸³´Ï´Ù. ¹è¼ÛÀÏÁ¤Àº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.

¿ø°Ý ȯÀÚ ¸ð´ÏÅ͸µ ºÐ¾ß ÀΰøÁö´É(Artificial Intelligence in Remote Patient Monitoring) ½ÃÀåÀÇ 2023³â ½ÃÀå ±Ô¸ð´Â 14¾ï ´Þ·¯·Î Æò°¡µÇ¾ú½À´Ï´Ù. 2024³â¿¡´Â 17¾ï 7,000¸¸ ´Þ·¯¿¡ À̸¦ °ÍÀ¸·Î ¿¹ÃøµÇ¸ç CAGR 25.83%·Î ¼ºÀåÇÏ¿© 2030³â¿¡´Â 70¾ï 3,000¸¸ ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù.

¿ø°Ý ȯÀÚ ¸ð´ÏÅ͸µ(RPM) ºÐ¾ß ÀΰøÁö´É(AI)ÀÇ ¹üÀ§´Â AI ±â¼úÀ» Ȱ¿ëÇÏ¿© ¿ø°ÝÀ¸·Î ȯÀÚ °Ç°­ µ¥ÀÌÅ͸¦ ¼öÁýÇÏ°í ºÐ¼®ÇÏ´Â °úÁ¤À» Çâ»ó½ÃŰ´Â °ÍÀ» Æ÷ÇÔÇÕ´Ï´Ù. ¿©±â¿¡´Â Ȱ·Â ¡ÈÄ ¸ð´ÏÅ͸µ, ¸¸¼º Áúȯ °ü¸®, ÀáÀçÀûÀÎ °Ç°­ À̺¥Æ® ¿¹ÃøÀÌ Æ÷ÇԵ˴ϴÙ. ¸¸¼º ÁúȯÀÇ À¯º´·ü Áõ°¡, Ȩ ÇコÄɾ ´ëÇÑ Çʿ伺 Áõ°¡, °¡Ä¡ ±â¹Ý Äɾî·ÎÀÇ ÀüȯÀ¸·Î ÀÎÇØ AI ±â¹Ý RPMÀº ¸Å¿ì Áß¿äÇÕ´Ï´Ù. ÀÀ¿ë ºÐ¾ß´Â ¿þ¾î·¯ºí °Ç°­ ±â±âºÎÅÍ AI ±â¹Ý ¿ø°Ý ÀÇ·á Ç÷§Æû¿¡ À̸£±â±îÁö ´Ù¾çÇϸç, ÀÇ·á Á¦°øÀÚ¿¡°Ô ½Ç½Ã°£ µ¥ÀÌÅÍ ÀλçÀÌÆ®¸¦ Á¦°øÇÕ´Ï´Ù. ÁÖ¿ä ÃÖÁ¾ »ç¿ëÀڷδ º´¿ø, Ŭ¸®´Ð, Ȩ ÇコÄɾî, ȯÀÚ °³ÀÎ »ç¿ë µîÀÌ ÀÖ½À´Ï´Ù. ½ÃÀåÀÇ ¼ºÀåÀº ³ëÀÎ Àα¸ Áõ°¡, ¹«¼± ±â¼úÀÇ ¹ßÀü, Áö¿øÀûÀÎ ÀÇ·á Á¤Ã¥ÀÇ ¿µÇâÀ» ¹Þ½À´Ï´Ù. ÀáÀçÀûÀÎ ±âȸ´Â ¿¹Ãø ºÐ¼®À» Çâ»ó½ÃÄÑ È¯ÀÚ °á°ú¸¦ °³¼±Çϰí ÀÇ·á ºñ¿ëÀ» Àý°¨Çϱâ À§ÇØ AI¸¦ IoT ÀåÄ¡¿Í ÅëÇÕÇÏ´Â °ÍÀÔ´Ï´Ù. ±â¾÷µéÀº ¶ÇÇÑ ÀÇ·á ÀÎÇÁ¶ó°¡ ºü¸£°Ô ¹ßÀüÇϰí ÀÖ´Â ½ÅÈï ½ÃÀå¿¡¼­ ¼­ºñ½º¸¦ È®ÀåÇÏ´Â µ¥ ÁýÁßÇØ¾ß ÇÕ´Ï´Ù. ±×·¯³ª µ¥ÀÌÅÍ ÇÁ¶óÀ̹ö½Ã ¹®Á¦, AI ±â¹Ý RPM ½Ã½ºÅÛÀÇ ³ôÀº ºñ¿ë, ±ÔÁ¦ Àå¾Ö¹°°ú °°Àº µµÀü °úÁ¦´Â ½ÃÀå ¼ºÀåÀ» Á¦ÇÑÇÒ ¼ö ÀÖ½À´Ï´Ù. Çõ½Å ±âȸ¿¡´Â ºñ¿ë È¿À²ÀûÀÎ AI ¾Ë°í¸®Áò °³¹ß, ´Ù¾çÇÑ ÀÇ·á ±â±â °£ÀÇ »óÈ£ ¿î¿ë¼º Çâ»ó, ¸Ó½Å·¯´× ¸ðµ¨À» ÅëÇÑ AIÀÇ ÀÇ»ç °áÁ¤ ´É·Â Çâ»ó µîÀÌ Æ÷ÇԵ˴ϴÙ. ¿¬±¸´Â ȯÀÚ ¸ÂÃãÈ­ ¹× Ä¡·á ¼øÀÀµµ Áõ°¡¿¡ ÀÖ¾î AIÀÇ ¿ªÇÒÀ» ´õ¿í ޱ¸ÇÒ ¼ö ÀÖ½À´Ï´Ù. ÀÌ ½ÃÀåÀº ºü¸¥ ±â¼ú ¹ßÀü°ú °æÀï ȯ°æÀÇ ¼ºÀåÀ¸·Î Ư¡Áö¾îÁö¸ç, ÁÖ¿ä ¾÷üµéÀº RPM ¿ª·® Çâ»óÀ» À§ÇØ AI ±â¼ú °³¼±°ú ÆÄÆ®³Ê½Ê¿¡ ÅõÀÚÇÕ´Ï´Ù. ¼ºÀå ÀáÀç·ÂÀ» ±Ø´ëÈ­Çϱâ À§ÇØ ±â¾÷µéÀº µ¥ÀÌÅÍ º¸¾È ¹®Á¦¸¦ ÇØ°áÇÏ°í ±ÔÁ¦ Áؼö¸¦ º¸ÀåÇϸç, ¿øÈ°Çϰí È¿À²ÀûÀÎ ÀÇ·á ¼­ºñ½º Á¦°øÀ» À§ÇÑ ÀÇ·á Àü¹®°¡ÀÇ ¿ä±¸¿Í ȯÀÚÀÇ ¼±È£¿¡ ºÎÇÕÇÏ´Â AI ±â¹Ý RPM ¼Ö·ç¼ÇÀ» Áö¼ÓÀûÀ¸·Î Çõ½ÅÇØ¾ß ÇÕ´Ï´Ù.

ÁÖ¿ä ½ÃÀå Åë°è
±âÁØ¿¬µµ(2023³â) 14¾ï ´Þ·¯
ÃßÁ¤¿¬µµ(2024³â) 17¾ï 7,000¸¸ ´Þ·¯
¿¹Ãø¿¬µµ(2030³â) 70¾ï 3,000¸¸ ´Þ·¯
CAGR(%) 25.83%

½ÃÀå ¿ªÇÐ : ºü¸£°Ô ÁøÈ­ÇÏ´Â ¿ø°Ý ȯÀÚ ¸ð´ÏÅ͸µ ºÐ¾ß ÀΰøÁö´É ½ÃÀåÀÇ ÁÖ¿ä ÀλçÀÌÆ® °ø°³

¿ø°Ý ȯÀÚ ¸ð´ÏÅ͸µ ºÐ¾ß ÀΰøÁö´É ½ÃÀåÀº ¼ö¿ä ¹× °ø±ÞÀÇ ¿ªµ¿ÀûÀÎ »óÈ£ ÀÛ¿ë¿¡ ÀÇÇØ º¯È­¸¦ °Þ°í ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ º¯È­ÇÏ´Â ½ÃÀå ¿ªÇÐÀ» ÀÌÇØÇÏ¸é ºñÁî´Ï½º Á¶Á÷Àº Á¤º¸¿¡ ÀÔ°¢ÇÑ ÅõÀÚ °áÁ¤À» ³»¸®°í, Àü·«Àû ÀÇ»ç °áÁ¤À» °³¼±Çϸç, »õ·Î¿î ±âȸ¸¦ Æ÷ÂøÇÒ ¼ö ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ Æ®·»µå¸¦ Á¾ÇÕÀûÀ¸·Î ÆÄ¾ÇÇÔÀ¸·Î½á ºñÁî´Ï½º Á¶Á÷Àº Á¤Ä¡Àû, Áö¸®Àû, ±â¼úÀû, »çȸÀû, °æÁ¦Àû ¿µ¿ª¿¡¼­ ´Ù¾çÇÑ À§ÇèÀ» ¿ÏÈ­ÇÏ´Â µ¿½Ã¿¡ ¼ÒºñÀÚ Çൿ°ú ±×°ÍÀÌ Á¦Á¶ ºñ¿ë ¹× ±¸¸Å Æ®·»µå¿¡ ¹ÌÄ¡´Â ¿µÇâÀ» ´õ ¸íÈ®ÇÏ°Ô ÀÌÇØÇÒ ¼ö ÀÖ½À´Ï´Ù.

  • ½ÃÀå ¼ºÀå ÃËÁø¿äÀÎ
    • ½Ç½Ã°£ ¸ð´ÏÅ͸µ°ú ȯÀÚ Âü¿© Çâ»óÀ» À§ÇÑ Ã¤Åà Áõ°¡
    • °ü¸® ÃÖÀûÈ­ ¹× ÈÞ¸Õ ¿¡·¯ °¨¼Ò¿¡ ´ëÇÑ ¼ö¿ä Áõ°¡
  • ½ÃÀå ¼ºÀå ¾ïÁ¦¿äÀÎ
    • ¿ø°ÝÁö¿¡¼­ ÀÎ½Ä ºÎÁ·
  • ½ÃÀå ±âȸ
    • AI Åø¿¡¼­ º¸¾È ±â´É ÅëÇÕ Áõ°¡
    • ¿þ¾î·¯ºí ±â¼ú·Î ÀÌÇà
  • ½ÃÀå °úÁ¦
    • »çÀ̹ö º¸¾È°ú ÇÁ¶óÀ̹ö½Ã¿¡ ´ëÇÑ ¿ì·Á°¡ Áõ°¡

Porter's Five Forces : ¿ø°Ý ȯÀÚ ¸ð´ÏÅ͸µ ºÐ¾ß ÀΰøÁö´É ½ÃÀåÀ» Ž»öÇÏ´Â Àü·« µµ±¸

Porter's Five Forces ÇÁ·¹ÀÓ¿öÅ©´Â ½ÃÀå »óȲ°æÀï ±¸µµ¸¦ ÀÌÇØÇÏ´Â Áß¿äÇÑ µµ±¸ÀÔ´Ï´Ù. ÀÌ ÇÁ·¹ÀÓ¿öÅ©´Â ºñÁî´Ï½º Á¶Á÷ÀÌ °æÀïÀû À§Ä¡¸¦ Æò°¡Çϰí Àü·«Àû ±âȸ¸¦ Ž»öÇÒ ¼ö ÀÖ´Â ¸íÈ®ÇÑ ¹æ¹ý·ÐÀ» Á¦°øÇÕ´Ï´Ù. ÀÌ ÇÁ·¹ÀÓ¿öÅ©´Â ±â¾÷ÀÌ ½ÃÀå ³» ÈûÀÇ ¿ªÇÐ °ü°è¸¦ Æò°¡ÇÏ°í »õ·Î¿î º¥Ã³ÀÇ ¼öÀͼºÀ» ÆÇ´ÜÇÏ´Â µ¥ µµ¿òÀÌ µË´Ï´Ù. ÀÌ·¯ÇÑ ÀλçÀÌÆ®¸¦ ÅëÇØ ºñÁî´Ï½º Á¶Á÷Àº °­Á¡À» Ȱ¿ëÇÏ°í ¾àÁ¡À» ÇØ°áÇϸç ÀáÀçÀûÀÎ ¹®Á¦¸¦ ¹æÁöÇÏ¿© º¸´Ù ź·ÂÀûÀÎ ½ÃÀå Æ÷Áö¼Å´×À» È®º¸ÇÒ ¼ö ÀÖ½À´Ï´Ù.

PESTLE ºÐ¼® : ¿ø°Ý ȯÀÚ ¸ð´ÏÅ͸µ ºÐ¾ß ÀΰøÁö´É ½ÃÀåÀÇ ¿ÜºÎ ¿µÇâÀ» ÆÄ¾Ç

¿ÜºÎ °Å½Ã ȯ°æ ¿äÀÎÀº ¿ø°Ý ȯÀÚ ¸ð´ÏÅ͸µ ºÐ¾ß ÀΰøÁö´É ½ÃÀåÀÇ ¼º°ú ¿ªÇÐÀ» Çü¼ºÇÏ´Â µ¥ ¸Å¿ì Áß¿äÇÑ ¿ªÇÒÀ» ÇÕ´Ï´Ù. Á¤Ä¡, °æÁ¦, »çȸ, ±â¼ú, ¹ý·ü ¹× ȯ°æ ¿äÀÎ ºÐ¼®Àº ÀÌ·¯ÇÑ ¿µÇâÀ» Ž»öÇÏ´Â µ¥ ÇÊ¿äÇÑ Á¤º¸¸¦ Á¦°øÇÕ´Ï´Ù. PESTLE ¿äÀÎÀ» °ËÅäÇÔÀ¸·Î½á ±â¾÷Àº ÀáÀçÀûÀÎ À§Çè°ú ±âȸ¸¦ ´õ Àß ÀÌÇØÇÒ ¼ö ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ºÐ¼®À» ÅëÇØ ºñÁî´Ï½º Á¶Á÷Àº ±ÔÁ¦, ¼ÒºñÀÚ ¼±È£µµ, °æÁ¦ µ¿ÇâÀÇ º¯È­¸¦ ¿¹ÃøÇÏ¿© ¼±Á¦ÀûÀÌ°í ¹Ì·¡ ÁöÇâÀûÀÎ ÀÇ»ç °áÁ¤À» ³»¸± Áغñ¸¦ ÇÒ ¼ö ÀÖ½À´Ï´Ù.

½ÃÀå Á¡À¯À² ºÐ¼® : ¿ø°Ý ȯÀÚ ¸ð´ÏÅ͸µ ºÐ¾ß ÀΰøÁö´É ½ÃÀå °æÀï ±¸µµ ÆÄ¾Ç

¿ø°Ý ȯÀÚ ¸ð´ÏÅ͸µ ºÐ¾ß ÀΰøÁö´É ½ÃÀåÀÇ »ó¼¼ÇÑ ½ÃÀå Á¡À¯À² ºÐ¼®À» ÅëÇØ °ø±Þ¾÷üÀÇ ¼º°ú¸¦ Á¾ÇÕÀûÀ¸·Î Æò°¡¸¦ Á¦°øÇÕ´Ï´Ù. ±â¾÷Àº ¸ÅÃâ, °í°´ ±â¹Ý, ¼ºÀå·ü µîÀÇ ÁÖ¿ä ÁöÇ¥¸¦ ºñ±³ÇÏ¿© ÀÚ»çÀÇ °æÀïÀû À§Ä¡¸¦ ÆÄ¾ÇÇÒ ¼ö ÀÖ½À´Ï´Ù. ÀÌ ºÐ¼®Àº ½ÃÀå ÁýÁßµµ, ¼¼ºÐÈ­, ÅëÇÕ Ãß¼¼¸¦ °­Á¶ÇÏ¿© º¥´õ°¡ °æÀïÀÌ Ä¡¿­ÇØÁö´Â ȯ°æ¿¡¼­ ÀÔÁö¸¦ °­È­ÇÏ´Â Àü·«Àû °áÁ¤À» ³»¸®´Â µ¥ ÇÊ¿äÇÑ ÀλçÀÌÆ®¸¦ Á¦°øÇÕ´Ï´Ù.

FPNV Æ÷Áö¼Å´× ¸ÅÆ®¸¯½º : ¿ø°Ý ȯÀÚ ¸ð´ÏÅ͸µ ºÐ¾ß ÀΰøÁö´É ½ÃÀå¿¡¼­ °ø±Þ¾÷üÀÇ ¼º°ú Æò°¡

FPNV Æ÷Áö¼Å´× ¸ÅÆ®¸¯½º´Â ¿ø°Ý ȯÀÚ ¸ð´ÏÅ͸µ ºÐ¾ß ÀΰøÁö´É ½ÃÀå¿¡¼­ º¥´õ¸¦ Æò°¡ÇÏ´Â Áß¿äÇÑ µµ±¸ÀÔ´Ï´Ù. ÃæºÐÇÑ Á¤º¸¸¦ ¹ÙÅÁÀ¸·Î ÀÇ»ç °áÁ¤À» ³»¸± ¼ö ÀÖ½À´Ï´Ù.

Àü·« ºÐ¼® ¹× Á¦¾È : ¿ø°Ý ȯÀÚ ¸ð´ÏÅ͸µ ºÐ¾ß ÀΰøÁö´É ½ÃÀåÀÇ ¼º°ø¿¡ ´ëÇÑ ±æ ã±â

¿ø°Ý ȯÀÚ ¸ð´ÏÅ͸µ ºÐ¾ß ÀΰøÁö´É ½ÃÀåÀÇ Àü·« ºÐ¼®Àº ¼¼°è ½ÃÀå¿¡¼­ ÀÔÁö °­È­¸¦ ¸ñÇ¥·Î ÇÏ´Â ±â¾÷¿¡ ÇʼöÀûÀÎ ¿ä¼ÒÀÔ´Ï´Ù. ÀÌ Á¢±Ù¹ýÀ» ÅëÇØ °æÀï ±¸µµ¿¡¼­ °úÁ¦¸¦ ±Øº¹ÇÏ°í »õ·Î¿î ºñÁî´Ï½º ±âȸ¸¦ Ȱ¿ëÇÏ¿© Àå±âÀûÀÎ ¼º°øÀ» ÀÌ·ç±âÀ§ÇÑ ½Ã½ºÅÛÀ» ±¸Ãà ÇÒ ¼ö ÀÖ½À´Ï´Ù.

ÀÌ º¸°í¼­´Â ÁÖ¿ä °ü½É ºÐ¾ß¸¦ Æ÷°ýÇÏ´Â ½ÃÀåÀÇ Á¾ÇÕÀûÀÎ ºÐ¼®À» Á¦°øÇÕ´Ï´Ù.

1. ½ÃÀå ħÅõ : ÇöÀç ½ÃÀå ȯ°æÀÇ »ó¼¼ÇÑ °ËÅä, ÁÖ¿ä ±â¾÷ÀÇ ±¤¹üÀ§ÇÑ µ¥ÀÌÅÍ, ½ÃÀå µµ´Þ¹üÀ§ ¹× Àü¹ÝÀûÀÎ ¿µÇâ·ÂÀ» Æò°¡ÇÕ´Ï´Ù.

2. ½ÃÀå °³Ã´µµ : ½ÅÈï ½ÃÀåÀÇ ¼ºÀå ±âȸ¸¦ ÆÄ¾ÇÇÏ°í ±âÁ¸ ºÐ¾ßÀÇ È®Àå °¡´É¼ºÀ» Æò°¡ÇÏ¸ç ¹Ì·¡ ¼ºÀåÀ» À§ÇÑ Àü·«Àû ·Îµå¸ÊÀ» Á¦°øÇÕ´Ï´Ù.

3. ½ÃÀå ´Ù¾çÈ­ : ÃÖ±Ù Á¦Ç° Ãâ½Ã, ¹Ì°³Ã´ Áö¿ª, ¾÷°èÀÇ ÁÖ¿ä Áøº¸, ½ÃÀåÀ» Çü¼ºÇÏ´Â Àü·«Àû ÅõÀÚ¸¦ ºÐ¼®ÇÕ´Ï´Ù.

4. °æÀï Æò°¡ ¹× Á¤º¸ : °æÀï ±¸µµ¸¦ öÀúÈ÷ ºÐ¼®ÇÏ¿© ½ÃÀå Á¡À¯À², »ç¾÷ Àü·«, Á¦Ç° Æ÷Æ®Æú¸®¿À, ÀÎÁõ, ±ÔÁ¦ ´ç±¹ ½ÂÀÎ, ƯÇã µ¿Çâ, ÁÖ¿ä ±â¾÷ÀÇ ±â¼ú Áøº¸ µîÀ» °ËÁõÇÕ´Ï´Ù.

5. Á¦Ç° °³¹ß ¹× Çõ½Å : ¹Ì·¡ ½ÃÀå ¼ºÀåÀ» °¡¼ÓÇÒ °ÍÀ¸·Î ¿¹»óµÇ´Â ÃÖ÷´Ü ±â¼ú, R&D Ȱµ¿, Á¦Ç° Çõ½ÅÀ» °­Á¶ÇÕ´Ï´Ù.

¶ÇÇÑ ÀÌÇØ°ü°èÀÚ°¡ ÃæºÐÇÑ Á¤º¸¸¦ ¾ò°í ÀÇ»ç°áÁ¤À» ÇÒ ¼ö ÀÖµµ·Ï Áß¿äÇÑ Áú¹®¿¡ ´ë´äÇϰí ÀÖ½À´Ï´Ù.

1. ÇöÀç ½ÃÀå ±Ô¸ð¿Í ÇâÈÄ ¼ºÀå ¿¹ÃøÀº?

2. ÃÖ°íÀÇ ÅõÀÚ ±âȸ¸¦ Á¦°øÇÏ´Â Á¦Ç°, ºÎ¹® ¹× Áö¿ªÀº?

3. ½ÃÀåÀ» Çü¼ºÇÏ´Â ÁÖ¿ä ±â¼ú µ¿Çâ°ú ±ÔÁ¦ÀÇ ¿µÇâÀº?

4. ÁÖ¿ä º¥´õÀÇ ½ÃÀå Á¡À¯À²°ú °æÀï Æ÷Áö¼ÇÀº?

5. º¥´õ ½ÃÀå ÁøÀÔ¡¤Ã¶¼ö Àü·«ÀÇ ¿øµ¿·ÂÀÌ µÇ´Â ¼öÀÍ¿ø°ú Àü·«Àû ±âȸ´Â?

¸ñÂ÷

Á¦1Àå ¼­¹®

Á¦2Àå Á¶»ç ¹æ¹ý

Á¦3Àå ÁÖ¿ä ¿ä¾à

Á¦4Àå ½ÃÀå °³¿ä

Á¦5Àå ½ÃÀå ÀλçÀÌÆ®

  • ½ÃÀå ¿ªÇÐ
    • ¼ºÀå ÃËÁø¿äÀÎ
      • ½Ç½Ã°£ ¸ð´ÏÅ͸µ ¹× ȯÀÚ Âü¿© Çâ»óÀ» À§ÇÑ Ã¤Åà Áõ°¡
      • °ü¸® ÃÖÀûÈ­ ¹× ÀÎÀû ½Ç¼ö °¨¼Ò¿¡ ´ëÇÑ ¼ö¿ä Áõ°¡
    • ¾ïÁ¦¿äÀÎ
      • ¿ø°ÝÁö¿¡¼­ ÀÎ½Ä ºÎÁ·
    • ±âȸ
      • AI Åø¿¡ ´ëÇÑ º¸¾È ±â´É ÅëÇÕ Áõ°¡
      • ¿þ¾î·¯ºí ±â¼ú·ÎÀÇ Àüȯ
    • °úÁ¦
      • »çÀ̹ö º¸¾È ¹× ÇÁ¶óÀ̹ö½Ã¿¡ ´ëÇÑ ¿ì·Á°¡ Áõ°¡
  • ½ÃÀå ¼¼ºÐÈ­ ºÐ¼®
  • Porter's Five Forces ºÐ¼®
  • PESTEL ºÐ¼®
    • Á¤Ä¡Àû
    • °æÁ¦Àû
    • »çȸÀû
    • ±â¼úÀû
    • ¹ýÀû
    • ȯ°æÀû

Á¦6Àå ¿ø°Ý ȯÀÚ ¸ð´ÏÅ͸µ ºÐ¾ß ÀΰøÁö´É ½ÃÀå : ¼Ö·ç¼Çº°

  • Çϵå¿þ¾î
  • ¼­ºñ½º
  • ¼ÒÇÁÆ®¿þ¾î

Á¦7Àå ¿ø°Ý ȯÀÚ ¸ð´ÏÅ͸µ ºÐ¾ß ÀΰøÁö´É ½ÃÀå : ¿ëµµº°

  • ¸¶Ãë ¸ð´ÏÅ͸µ
  • Ç÷´ç ¸ð´ÏÅ͸µ
  • ³ú ¸ð´ÏÅ͸µ
  • ½É¹Ú ¸®µë ¸ð´ÏÅ͸µ
  • ½É¹Ú¼ö ¸ð´ÏÅ͸µ
  • È£Èí ¸ð´ÏÅ͸µ
  • ¿Âµµ ¸ð´ÏÅ͸µ

Á¦8Àå ¾Æ¸Þ¸®Ä«ÀÇ ¿ø°Ý ȯÀÚ ¸ð´ÏÅ͸µ ºÐ¾ß ÀΰøÁö´É ½ÃÀå

  • ¾Æ¸£ÇîÆ¼³ª
  • ºê¶óÁú
  • ij³ª´Ù
  • ¸ß½ÃÄÚ
  • ¹Ì±¹

Á¦9Àå ¾Æ½Ã¾Æ ÅÂÆò¾çÀÇ ¿ø°Ý ȯÀÚ ¸ð´ÏÅ͸µ ºÐ¾ß ÀΰøÁö´É ½ÃÀå

  • È£ÁÖ
  • Áß±¹
  • Àεµ
  • Àεµ³×½Ã¾Æ
  • ÀϺ»
  • ¸»·¹À̽þÆ
  • Çʸ®ÇÉ
  • ½Ì°¡Æ÷¸£
  • Çѱ¹
  • ´ë¸¸
  • ű¹
  • º£Æ®³²

Á¦10Àå À¯·´¡¤Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«ÀÇ ¿ø°Ý ȯÀÚ ¸ð´ÏÅ͸µ ºÐ¾ß ÀΰøÁö´É ½ÃÀå

  • µ§¸¶Å©
  • ÀÌÁýÆ®
  • Çɶõµå
  • ÇÁ¶û½º
  • µ¶ÀÏ
  • À̽º¶ó¿¤
  • ÀÌÅ»¸®¾Æ
  • ³×´ú¶õµå
  • ³ªÀÌÁö¸®¾Æ
  • ³ë¸£¿þÀÌ
  • Æú¶õµå
  • īŸ¸£
  • ·¯½Ã¾Æ
  • »ç¿ìµð¾Æ¶óºñ¾Æ
  • ³²¾ÆÇÁ¸®Ä«°øÈ­±¹
  • ½ºÆäÀÎ
  • ½º¿þµ§
  • ½ºÀ§½º
  • ÅÍŰ
  • ¾Æ¶ø¿¡¹Ì¸®Æ®(UAE)
  • ¿µ±¹

Á¦11Àå °æÀï ±¸µµ

  • ½ÃÀå Á¡À¯À² ºÐ¼®(2023³â)
  • FPNV Æ÷Áö¼Å´× ¸ÅÆ®¸¯½º(2023³â)
  • °æÀï ½Ã³ª¸®¿À ºÐ¼®
  • Àü·« ºÐ¼® ¹× Á¦¾È

±â¾÷ ¸ñ·Ï

  • Accuhealth Global Inc
  • AiCure, LLC
  • Apexon
  • Binah.ai Ltd
  • Biofourmis Inc.
  • Cardiomo Care, Inc.
  • ChroniSense Medical, Ltd.
  • CU-BX Automotive Technologies Ltd.
  • Current Health Limited
  • DrKumo Inc.
  • Ejenta, Inc.
  • Feebris Ltd.
  • Gyant.com, Inc.
  • Huma Therapeutics Limited
  • iBeat, Inc.
  • iHealth Labs, Inc.
  • Implicity
  • Jorie Healthcare Patners LLC
  • Myia Labs Inc.
  • Neteera Technologies Ltd.
  • Philips Healthcare
  • Resideo Technologies, Inc
  • Senseonics Holdings, Inc
  • Somatix Inc.
  • Zephyr AI
LYJ

The Artificial Intelligence in Remote Patient Monitoring Market was valued at USD 1.40 billion in 2023, expected to reach USD 1.77 billion in 2024, and is projected to grow at a CAGR of 25.83%, to USD 7.03 billion by 2030.

The scope of artificial intelligence (AI) in remote patient monitoring (RPM) involves leveraging AI technologies to enhance the process of collecting and analyzing patient health data remotely. This includes monitoring vital signs, managing chronic diseases, and predicting potential health events. RPM powered by AI is crucial due to the rising prevalence of chronic diseases, the increasing need for home healthcare, and the shift towards value-based care. Applications range from wearable health devices to AI-driven telehealth platforms, providing real-time data insights to healthcare providers. Key end-users include hospitals, clinics, home healthcare, and personal use by patients for better health management. The market's growth is influenced by the expanding geriatric population, advances in wireless technology, and supportive healthcare policies. Potential opportunities lie in integrating AI with IoT devices to enhance predictive analytics, thereby improving patient outcomes and reducing healthcare costs. Companies should also focus on expanding services in emerging markets, where healthcare infrastructure is rapidly developing. However, challenges such as data privacy concerns, high costs of AI-based RPM systems, and regulatory hurdles can limit market growth. Innovation opportunities include developing cost-effective AI algorithms, improving interoperability between different health devices, and enhancing AI's decision-making capabilities through machine learning models. Research could further explore AI's role in personalizing patient care and increasing treatment adherence. The market is characterized by rapid technological advancements and a growing competitive landscape, with major players investing in AI technology improvements and partnerships to enhance RPM capabilities. To maximize growth potentials, companies should address data security issues, ensure regulatory compliance, and continue to innovate in AI-driven RPM solutions that align with healthcare professionals' needs and patients' preferences for seamless and efficient healthcare delivery.

KEY MARKET STATISTICS
Base Year [2023] USD 1.40 billion
Estimated Year [2024] USD 1.77 billion
Forecast Year [2030] USD 7.03 billion
CAGR (%) 25.83%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Artificial Intelligence in Remote Patient Monitoring Market

The Artificial Intelligence in Remote Patient Monitoring Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Rise in adoption for real time monitoring and to improve patient engagement
    • Growing demand to optimize management and lower human errors
  • Market Restraints
    • Lack of awareness in remote areas
  • Market Opportunities
    • Rising integration of security features in AI tools
    • Shift in towards wearable technology
  • Market Challenges
    • Increasing concern related to cybersecurity and privacy

Porter's Five Forces: A Strategic Tool for Navigating the Artificial Intelligence in Remote Patient Monitoring Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Artificial Intelligence in Remote Patient Monitoring Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Artificial Intelligence in Remote Patient Monitoring Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Artificial Intelligence in Remote Patient Monitoring Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Artificial Intelligence in Remote Patient Monitoring Market

A detailed market share analysis in the Artificial Intelligence in Remote Patient Monitoring Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Artificial Intelligence in Remote Patient Monitoring Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Artificial Intelligence in Remote Patient Monitoring Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Artificial Intelligence in Remote Patient Monitoring Market

A strategic analysis of the Artificial Intelligence in Remote Patient Monitoring Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Artificial Intelligence in Remote Patient Monitoring Market, highlighting leading vendors and their innovative profiles. These include Accuhealth Global Inc, AiCure, LLC, Apexon, Binah.ai Ltd, Biofourmis Inc., Cardiomo Care, Inc., ChroniSense Medical, Ltd., CU-BX Automotive Technologies Ltd., Current Health Limited, DrKumo Inc., Ejenta, Inc., Feebris Ltd., Gyant.com, Inc., Huma Therapeutics Limited, iBeat, Inc., iHealth Labs, Inc., Implicity, Jorie Healthcare Patners LLC, Myia Labs Inc., Neteera Technologies Ltd., Philips Healthcare, Resideo Technologies, Inc, Senseonics Holdings, Inc, Somatix Inc., and Zephyr AI.

Market Segmentation & Coverage

This research report categorizes the Artificial Intelligence in Remote Patient Monitoring Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Solution, market is studied across Hardware, Services, and Software.
  • Based on Application, market is studied across Anesthesia Monitoring, Blood Glucose Monitoring, Brain Monitoring, Cardiac Rhythm Monitoring, Heart Rate Monitoring, Respiratory Monitoring, and Temperature Monitoring.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Rise in adoption for real time monitoring and to improve patient engagement
      • 5.1.1.2. Growing demand to optimize management and lower human errors
    • 5.1.2. Restraints
      • 5.1.2.1. Lack of awareness in remote areas
    • 5.1.3. Opportunities
      • 5.1.3.1. Rising integration of security features in AI tools
      • 5.1.3.2. Shift in towards wearable technology
    • 5.1.4. Challenges
      • 5.1.4.1. Increasing concern related to cybersecurity and privacy
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Artificial Intelligence in Remote Patient Monitoring Market, by Solution

  • 6.1. Introduction
  • 6.2. Hardware
  • 6.3. Services
  • 6.4. Software

7. Artificial Intelligence in Remote Patient Monitoring Market, by Application

  • 7.1. Introduction
  • 7.2. Anesthesia Monitoring
  • 7.3. Blood Glucose Monitoring
  • 7.4. Brain Monitoring
  • 7.5. Cardiac Rhythm Monitoring
  • 7.6. Heart Rate Monitoring
  • 7.7. Respiratory Monitoring
  • 7.8. Temperature Monitoring

8. Americas Artificial Intelligence in Remote Patient Monitoring Market

  • 8.1. Introduction
  • 8.2. Argentina
  • 8.3. Brazil
  • 8.4. Canada
  • 8.5. Mexico
  • 8.6. United States

9. Asia-Pacific Artificial Intelligence in Remote Patient Monitoring Market

  • 9.1. Introduction
  • 9.2. Australia
  • 9.3. China
  • 9.4. India
  • 9.5. Indonesia
  • 9.6. Japan
  • 9.7. Malaysia
  • 9.8. Philippines
  • 9.9. Singapore
  • 9.10. South Korea
  • 9.11. Taiwan
  • 9.12. Thailand
  • 9.13. Vietnam

10. Europe, Middle East & Africa Artificial Intelligence in Remote Patient Monitoring Market

  • 10.1. Introduction
  • 10.2. Denmark
  • 10.3. Egypt
  • 10.4. Finland
  • 10.5. France
  • 10.6. Germany
  • 10.7. Israel
  • 10.8. Italy
  • 10.9. Netherlands
  • 10.10. Nigeria
  • 10.11. Norway
  • 10.12. Poland
  • 10.13. Qatar
  • 10.14. Russia
  • 10.15. Saudi Arabia
  • 10.16. South Africa
  • 10.17. Spain
  • 10.18. Sweden
  • 10.19. Switzerland
  • 10.20. Turkey
  • 10.21. United Arab Emirates
  • 10.22. United Kingdom

11. Competitive Landscape

  • 11.1. Market Share Analysis, 2023
  • 11.2. FPNV Positioning Matrix, 2023
  • 11.3. Competitive Scenario Analysis
  • 11.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Accuhealth Global Inc
  • 2. AiCure, LLC
  • 3. Apexon
  • 4. Binah.ai Ltd
  • 5. Biofourmis Inc.
  • 6. Cardiomo Care, Inc.
  • 7. ChroniSense Medical, Ltd.
  • 8. CU-BX Automotive Technologies Ltd.
  • 9. Current Health Limited
  • 10. DrKumo Inc.
  • 11. Ejenta, Inc.
  • 12. Feebris Ltd.
  • 13. Gyant.com, Inc.
  • 14. Huma Therapeutics Limited
  • 15. iBeat, Inc.
  • 16. iHealth Labs, Inc.
  • 17. Implicity
  • 18. Jorie Healthcare Patners LLC
  • 19. Myia Labs Inc.
  • 20. Neteera Technologies Ltd.
  • 21. Philips Healthcare
  • 22. Resideo Technologies, Inc
  • 23. Senseonics Holdings, Inc
  • 24. Somatix Inc.
  • 25. Zephyr AI
ºñ±³¸®½ºÆ®
0 °ÇÀÇ »óǰÀ» ¼±Åà Áß
»óǰ ºñ±³Çϱâ
Àüü»èÁ¦